Gentronix Limited Signs Three Year Agreement with GlaxoSmithKline for GreenScreen HC and BlueScreen HC Genotoxicity Assays

Published: Mar 03, 2010

MANCHESTER, UK--(BUSINESS WIRE)--Gentronix Limited Manchester, UK announced today that it has entered into a three year agreement with GlaxoSmithKline (GSK) to provide GreenScreen HC and BlueScreen HC genotoxicity assays for use by GSK in genotoxicity screening.

Back to news